304 related articles for article (PubMed ID: 32074407)
1. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
Lobbes MB; Lalji U; Houwers J; Nijssen EC; Nelemans PJ; van Roozendaal L; Smidt ML; Heuts E; Wildberger JE
Eur Radiol; 2014 Jul; 24(7):1668-76. PubMed ID: 24696228
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
[TBL] [Abstract][Full Text] [Related]
6. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
7. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
Xiang W; Rao H; Zhou L
Thorac Cancer; 2020 Jun; 11(6):1423-1432. PubMed ID: 32233072
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
[No Abstract] [Full Text] [Related]
13. Correlation Between Enhancement Intensity in Contrast Enhancement Spectral Mammography and Types of Kinetic Curves in Magnetic Resonance Imaging.
Rudnicki W; Heinze S; Piegza T; Pawlak M; Kojs Z; Łuczyńska E
Med Sci Monit; 2020 Mar; 26():e920742. PubMed ID: 32173716
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced spectral mammography in patients with MRI contraindications.
Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
[TBL] [Abstract][Full Text] [Related]
16. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
[TBL] [Abstract][Full Text] [Related]
18. Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China.
Wang Q; Li K; Wang L; Zhang J; Zhou Z; Feng Y
Springerplus; 2016; 5(1):763. PubMed ID: 27386249
[TBL] [Abstract][Full Text] [Related]
19. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance.
Hobbs MM; Taylor DB; Buzynski S; Peake RE
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
